In a regulatory filing, WW disclosed that, in a communication to employees on March 14, the company said it is on track to beat its previously provided Q1 FY24 guidance for end of period Clinical subscribers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on WW:
- WW International Anticipates Surpassing Q1 Clinical Subscriber Targets
- WW down after debt-focused publication says lenders preparing for debt talks
- WW lenders hire lawyers to prepare for debt talks, 9fin says
- WW strategy involves ‘winning at care’, says DA Davidson
- Short Report: Bears cut down exposure to crypto names as bitcoin price spikes